News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Reprogramming of human somatic cells to pluripotency with defined factors
Areas: Transcription Factors
In a recently published study, murine fibroblasts were reprogrammed directly to pluripotency by ectopic expression of the transcription factors Oct4, Sox2, Klf4 and Myc.
Given these data In-Hyun Park from Harvard University used the same factors to derive induced pluripotent stem (iPS) cells from fetal, neonatal and adult human primary cells. Among them were also dermal fibroblasts, taken from a human skin biopsy. Human iPS cells are similar to embryonic stem cells regarding morphologic features and gene expression and they even share the ability to form teratomas (germ cell tumours) in immune-deficient mice. Apparently, there exist factors capable of reprogramming human cells to pluripotency.
Pluripotency is a famous feature of the early embryo's cells. They can develop into all tissues of the organism and are therefore a promising tool of research. Embryonic stem cells are cell lines taken from an embryo, that keep their pluripotency.
Related antibodies on antibodies-online.com:
Oct4
Antibodies for the research area transcription factors: »Show antibodies
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

